Catalent to Partner with Trizell for Cell Therapy Manufacturing February 8, 2021 Auto Bot News 0 Through the agreement, Catalent will manufacture Trizell’s Phase I cell therapy for the treatment of micro- and macroangiopathies at its Belgium facility.